Marbofloxacin

CAS 115550-35-1 7 current records 1 historicalSmall Molecule

Who holds supplier records for Marbofloxacin? 7 organisations hold a current record for Marbofloxacin: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4) and India (3).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Marbofloxacin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/marbofloxacin

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Marbofloxacin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Marbofloxacin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Marbofloxacin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG EXCEL PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2018-301 - Rev 03
Marbofloxacin for veterinary use
Apr 2025—
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2021-449 - Rev 01
Marbofloxacin for veterinary use
Dec 2024—
NGL FINE-CHEM LIMITED MumbaiIN
CEP 2022-218 - Rev 00
Marbofloxacin for veterinary use
Sept 2024—
ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. ShangyuCN
R1-CEP 2017-019 - Rev 00
Marbofloxacin for veterinary use
Apr 2023—
ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. HengdianCN
R1-CEP 2016-269 - Rev 00
Marbofloxacin for veterinary use
Jan 2023—
WISDOM PHARMACEUTICAL CO., LTD. HaimenCN
R0-CEP 2020-126 - Rev 01
Marbofloxacin for veterinary use
Oct 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Marbofloxacin are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • ASAHI GLASS CO LTD
    Inactive DMF 10057 · filed Jan 1993

Overview

Marbofloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL478120).

Chemical identity

IUPAC name
7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
Canonical SMILES
CN1CCN(CC1)C2=C(C=C3C4=C2OCN(N4C=C(C3=O)C(=O)O)C)F
InChIKey
BPFYOAJNDMUVBL-UHFFFAOYSA-N
Synonyms
Marbocyl, Marbofloxacin, Marbofloxacine, Marbofloxacino, RO 09-1168, Zeniquin, Marbofloxacinum, Marbocyl FD, Marboquin, FluoroFlox, DELAQUIN, RefChem:55550

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Marbofloxacin?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Marbofloxacin: Aurore Life Sciences (India), AUTHENTERRA HEALTHCARE LLP (India), Ngl Fine Chem Limited (India), Wisdom Pharmaceutical Co., Ltd (China), Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. (China), Zhejiang Excel Pharmaceutical Company., Ltd. (China) and ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Marbofloxacin Drug Master Files are active?

Aurore Life Sciences (DMF 35484) and AUTHENTERRA HEALTHCARE LLP (DMF 43162). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Marbofloxacin records mean?

1 organisation has only inactive Type II DMFs for Marbofloxacin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Marbofloxacin have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Marbofloxacin on the EDQM register, including ZHEJIANG EXCEL PHARMACEUTICAL CO., LTD. Taizhou (CN), AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), NGL FINE-CHEM LIMITED Mumbai (IN), ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shangyu (CN), ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. Hengdian (CN) and WISDOM PHARMACEUTICAL CO., LTD. Haimen (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Marbofloxacin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Marbofloxacin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.